Atrium secures rights to WobensymN in US

By staff reporter

- Last updated on GMT

An American court has confirmed Atrium Innovation's exclusive US
rights to the supplement WobenzymN, which the company has indicated
could hold considerable commercial potential in the country.

With headquarters in Quebec, Canada, Atrium develops, manufactures and markets science-based products for the nutrition, chemical, pharmaceutical and cosmetic industries. According to company, US firm Marlyn Nutraceuticals was ordered by the US District Court to stop selling the WobenzymN trademark and related products. If this happens, the gains could be large for Atrium. The company claims annuals sales for the plant enzyme formulation - sold for joint, muscle, and tendon health, as well as to support a healthy immune system - to customers in Europe stand at over $90m. "We are pleased with this court ruling, which will allow us to start selling WobenzymN in the United States immediately and with no restrictions,"​ stated Pierre Fitzgibbon, president and CEO of Atrium Innovations. "This high-quality product, sold as an enzyme supplement in the US, offers a natural solution to very common conditions such as joint and muscle discomfort." ​ The company says it will now sell WobenzymN through its two American subsidiaries, Douglas Laboratories and Pure Encapsulations - which sell to 40,000 healthcare professionals in the US. According to Atrium, the product is known within the medical community in Germany and Eastern European countries. Wobenzym is the flagship product of Mucos Pharma, and is a combination of plant based enzymes trypsin and chymotrypsin, as well as the antioxidant flavonoid rutin. Mucos Pharma is the German affiliate of Mucos in the US - a company specializing in pharmaceuticals. "We also intend to draw on other specialized distribution networks that offer strong business potential,"​ said Fitzgibbon. "This decision signifies a major development for Atrium and will allow the company to accelerate its growth and development in the United States."

Related topics: Suppliers, Bone & joint health, Polyphenols

Related news

Show more

Related products

show more

How Polyphenols enhance probiotic benefits

How Polyphenols enhance probiotic benefits

BerryPharma® - the Expert in Berry Extracts | 10-Oct-2017 | Research Study

Researchers have recently identified the positive interactions between polyphenols and intestinal bacteria, leading to classification as a prebiotic function....

NattoPharma

12 Reasons MenaQ7® is the Superior Vitamin K2

NattoPharma USA, Inc. | 11-Sep-2017 | Data Sheet

Vitamin K2 as MK-7 supplements are truly changing the face of global health, benefiting old and young alike. We know this because NattoPharma has single-handedly...

Related suppliers

Follow us

Products

View more

Webinars